LEAP THERAPEUTICS INC's ticker is LPTX and the CUSIP is 52187K101. A total of 41 filers reported holding LEAP THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $4 | -99.2% | 12,670 | -98.9% | 0.00% | – |
| Q4 2022 | $498 | -99.9% | 1,106,298 | +134.1% | 0.00% | – |
| Q3 2022 | $416,000 | -69.2% | 472,632 | -59.8% | 0.00% | -100.0% |
| Q2 2022 | $1,352,000 | -50.4% | 1,175,530 | -24.6% | 0.00% | 0.0% |
| Q1 2022 | $2,727,000 | -58.8% | 1,558,099 | -23.6% | 0.00% | -66.7% |
| Q4 2021 | $6,611,000 | +3435.3% | 2,040,384 | +4277.2% | 0.00% | – |
| Q3 2021 | $187,000 | +325.0% | 46,614 | +72.8% | 0.00% | – |
| Q2 2021 | $44,000 | -72.0% | 26,979 | -67.3% | 0.00% | – |
| Q1 2021 | $157,000 | -26.3% | 82,447 | -12.8% | 0.00% | – |
| Q4 2020 | $213,000 | +334.7% | 94,504 | +278.5% | 0.00% | – |
| Q3 2020 | $49,000 | -89.1% | 24,971 | -88.4% | 0.00% | -100.0% |
| Q2 2020 | $451,000 | +369.8% | 215,987 | +301.2% | 0.00% | – |
| Q2 2019 | $96,000 | -8.6% | 53,841 | +323.6% | 0.00% | – |
| Q1 2018 | $105,000 | -16.7% | 12,710 | -42.5% | 0.00% | – |
| Q3 2017 | $126,000 | – | 22,121 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 2,664,400 | $2,345,000 | 2.45% |
| Key Client Fiduciary Advisors, LLC | 1,120,943 | $986,000 | 0.89% |
| Knott David M Jr | 900,000 | $792,000 | 0.33% |
| ACT CAPITAL MANAGEMENT, LLC | 265,000 | $233,000 | 0.32% |
| Perceptive Advisors | 7,472,148 | $6,575,000 | 0.19% |
| Tri Locum Partners LP | 711,798 | $626,000 | 0.17% |
| 683 Capital Management, LLC | 2,265,000 | $1,993,000 | 0.15% |
| Artal Group S.A. | 4,000,000 | $3,520,000 | 0.15% |
| TANG CAPITAL MANAGEMENT LLC | 1,250,000 | $1,100,000 | 0.14% |
| HealthCor Management, L.P. | 1,066,689 | $939,000 | 0.12% |